Korean Circ J.  2016 Jan;46(1):13-14. 10.4070/kcj.2016.46.1.13.

A Novel Approach for Identifying Ischemic Cardiomyopathy

• Choi EY

• KMID: 2223764
• DOI: http://doi.org/10.4070/kcj.2016.46.1.13

Abstract

No abstract available.

MeSH Terms

Cardiomyopathies*

Reference

1. Burch GE, Giles TD, Colcolough HL. Ischemic cardiomyopathy. Am Heart J. 1970; 79:291–292.

2. Atkinson JB, Virmani R. Congestive heart failure due to coronary artery disease without myocardial infarction: clinicopathologic description of an unusual cardiomyopathy. Hum Pathol. 1989; 20:1155–1162.

3. Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006; 113:1807–1816.

4. Felker GM, Shaw LK, O'Connor CM. A standardized definition of ischemic cardiomyopathy for use in clinical research. J Am Coll Cardiol. 2002; 39:210–218.

5. Tenenbaum A, Fisman EZ, Motro M. Toward a redefinition of ischemic cardiomyopathy: is it an indivisible entity? J Am Coll Cardiol. 2002; 40:205–206.

6. Bonow RO, Maurer G, Lee KL, et al. Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med. 2011; 364:1617–1625.

7. Kim EK, Chang SA, Choi JO, et al. Concordant and discordant cardiac magnetic resonance imaging delayed hyperenhancement patterns in patients with ischemic and non-ischemic cardiomyopathy. Korean Circ J. 2016; 46:41–47.

8. Assomull RG, Prasad SK, Lyne J, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol. 2006; 48:1977–1985.

9. Alter P, Rupp H, Adams P, et al. Occurrence of late gadolinium enhancement is associated with increased left ventricular wall stress and mass in patients with non-ischaemic dilated cardiomyopathy. Eur J Heart Fail. 2011; 13:937–944.

10. Unverferth DV, Baker PB, Swift SE, et al. Extent of myocardial fibrosis and cellular hypertrophy in dilated cardiomyopathy. Am J Cardiol. 1986; 57:816–820.